BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) ...
SAN MATEO, Calif.--(BUSINESS WIRE)--Cala, the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced meeting the primary endpoint on an interim analysis of a ...
Credit: Fasikl. The wearable, transcutaneous neurostimulation device delivers personalized therapy using a proprietary AI algorithm. The device will be available by prescription starting this year, ...
More than 7 million Americans struggle with essential tremor (ET), but only one in 10 ET patients is satisfied with their current treatment. Cala Health — a San Mateo, California-based bioelectronic ...
A wearable, artificial intelligence (AI)-driven, continuous-use transcutaneous peripheral nerve stimulation (TPNS) device was linked to significant improvement in upper limb tremor in adult patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback